Sunday, Dec 10, 2023
ELN-DAVID meeting at the ELN breakfast meeting at ASH
Manchester Grand Hyatt, San Diego, Market Place 1, Level 4. Check the program by clicking on “See more”.
See more
Meetings and Workshops
2022
2022 MFC-MRD workshop by Jacqueline Cloos and Angele Kelder at UMC Amsterdam
Find the full slide deck of this interactive workshop on the role of MRD in AML and the use of MFC-MRD here
See more
October 2nd 2023
European Educational Workshop on MRD in AML and CLL
We thank our sponsors for the generous support of the workshop.
Education and Training
Comprehensive Protocol to Sample and Process Bone Marrow for Assesing Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Detection of measurable residual disease (MRD) is an important prognostic biomarker for refining risk assessment and predicting relapse in acute myeloid leukemia (AML). These comprehensive guidelines and recommendations with best practices for consistent and accurate identification and detection of MRD may aid in making effective AML treatment decisions.